Growing interest in infection prevention in the Middle East

Bactiguard has received an order from the Middle East, comprising 2 000 central
venous catheters (BIP CVC) and 20 000 Foleys (BIP Foley). The delivery will take
place before the end of the year.
The Middle East is one of Bactiguard’s focus markets and continues to generate
repeat orders, so far primarily of Foley catheters. There is a growing interest
from the healthcare sector in the region to use Bactiguard’s products in
preventing healthcare associated infections.

“We are very pleased that we have received a large order for central venous
catheters, preventing catheter-related bloodstream infections, a severe
condition. Preventive measures are becoming more important as antibiotic
resistance is increasing and Bactiguard’s products can make a major difference
to exposed patients”, says Cecilia Edström, Director of Sales & New Business.

This is information that Bactiguard Holding AB (publ) is required to publish in
compliance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication on 23
November 2015, at 08.00.
For further information, please contact:
Ulrika Berglund, Head of External Affairs, mobile: 46 708 800 407
About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare
associated infections, reducing the use of antibiotics and saving lives by
developing and supplying infection prevention solutions for the healthcare
industry. The company’s patented coating prevents healthcare associated
infections by reducing bacterial adhesion and growth on medical devices.
Bactiguard®-coated urinary catheters are market leading in the US and Japan, and
in recent years the company has developed its own product portfolio of catheters
for the urinary and respiratory tract and the blood stream. Bactiguard is
currently in a strong expansion phase, focused on new markets in the Europe,
Middle East, Asia, Latin America and Southern Africa. The company has market
presence in some 50 countries and has about 60 employees. Its headquarters is
located in Stockholm and production facilities in Sweden and Malaysia.
Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at
www.bactiguard.com